After RAS inhibitors: what comes next in pancreatic cancer?
RAS inhibitors have opened a new chapter in the treatment of pancreatic cancer, but some tumours develop resistance to these drugs. Here, we explor...
Service News from Medical Oncology
Neus Falgàs and Laura Mezquita join the Clínic-IDIBAPS 50/50 Programme
Both professionals will pursue a clinician-scientist career pathway, dividing their time equally between clinical care and research.
The Spanish Cancer Association joins the Governing Board of the Clínic Barcelona Comprehensive Cancer Centre
The Spanish Cancer Association, through its Scientific Foundation, has joined the Governing Board of the Clínic Barcelona Comprehensive Cancer Cent...
Clínic Barcelona Comprehensive Cancer Centre participates in ASCO 2026 with key contributions in oncology
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is participating in the American Society of Clinica...
Antitumor activity of RAS inhibitors described for the first time in preclinical models of cholangiocarcinoma
A team from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre, has participated in an international study th...
The Chair of Innovation in Precision Oncology celebrates five years of advancing training, research and leadership in precision medicine
March 2026 marks five years since the creation of the Chair of Innovation in Precision Oncology (IOP), a strategic initiative of the University of...
World Colorectal Cancer Day: two studies from the COLONPREV project provide new insights to improve prevention
Today is World Colorectal Cancer Day, which aims to raise awareness about the disease and emphasises the importance of prevention and screening as...
Cured meats and cancer risk: why they are not comparable to tobacco
Every now and then, the same headline pops up: "Eating ham is as carcinogenic as smoking." This phrase sparks concern and spreads rapidly. But is i...
February: Cholangiocarcinoma Awareness Month
February, particularly February 19, is dedicated to raising awareness about cholangiocarcinoma, a rare tumour in our setting where most patients ar...
Viro-immunotherapy combination shows promising results in breast cancer patients with poor initial chemotherapy response
A study led by Clínic Barcelona Comprehensive Cancer Centre (4CB)- – driven by Clínic Barcelona, IDIBAPS and UB-, and sponsored by SOLTI, shows tha...